Andrew R. Blight

2006

In 2006, Andrew R. Blight earned a total compensation of $731K as Chief Scientific Officer at Acorda Therapeutics.

Compensation breakdown

Bonus$120,000
Option Awards$137,830
Salary$236,000
Stock Awards$237,213
Total$731,043

Blight received $237.2K in stock awards, accounting for 32% of the total pay in 2006.

Blight also received $120K in bonus, $137.8K in option awards and $236K in salary.

Rankings

In 2006, Andrew R. Blight's compensation ranked 3,790th out of 7,022 executives tracked by ExecPay. In other words, Blight earned more than 46.0% of executives.

ClassificationRankingPercentile
All
3,790
out of 7,022
46th
Division
Manufacturing
1,226
out of 2,413
49th
Major group
Chemicals And Allied Products
290
out of 673
57th
Industry group
Drugs
187
out of 518
64th
Industry
Biological Products, Except Diagnostic Substances
35
out of 112
69th
Source: SEC filing on April 30, 2009.

Blight's colleagues

We found four more compensation records of executives who worked with Andrew R. Blight at Acorda Therapeutics in 2006.

2006

Ron Cohen

Acorda Therapeutics

Chief Executive Officer

2006

Mary Fisher

Acorda Therapeutics

Chief Operating Officer

2006

Jane Wasman

Acorda Therapeutics

General Counsel

2006

David Lawrence

Acorda Therapeutics

Chief Financial Officer

You may also like